Bioavailability and Pharmacokinetic Studies of Eurycomanone from Eurycoma longifolia

Abstract

A validated HPLC analysis of eurycomanone (1), a bioactive quassinoid, in rat plasma following oral and intravenous administration of Eurycoma longifolia Jack extract was developed for pharmacokinetic and bioavailability studies. Relatively high plasma eurycomanone concentrations were detected after an intravenous injection of 10 mg/kg extract F2 containing 1.96 mg/kg of the quassinoid. However, it declined rapidly to zero after 8 h. Its mean elimination rate constant (k_e), biological half-life (t_1/2), volume of distribution (V_d) and clearance (CL) were 0.88 ± 0.19 h^-1, 1.00 ± 0.26 h, 0.68 ± 0.30 L/kg and 0.39 ± 0.08 L/h/kg, respectively. Following oral administration of eurycomanone, its C_max and T_max values were detected as 0.33 ± 0.03 μg/mL and 4.40 ± 0.98 h, respectively. The plasma concentration of the quassinoid after oral administration was much lower than after intravenous application in spite of the oral dose being 5 times higher. The results indicate that eurycomanone is poorly bioavailable when given orally. A comparison of the AUC_0→∞ obtained orally to that obtained after an intravenous administration (normalized for dose differences) revealed that the absolute bioavailability of the compound was low with 10.5 %. Furthermore, the compound appeared to be well distributed in the extravascular fluids because of its relatively high V_d value. The poor oral bioavailability was not attributed to instability problems because eurycomanone has been shown to be stable under different pH conditions. Thus, its poor oral bioavailability may be due to poor membrane permeability in view of its low P value and/or high first-pass metabolism.

Eurycoma longifolia Jack - Simaroubaceae - eurycomanone - pharmacokinetics - bioavailability

References

• 1 Chan K L, Choo C Y, Morita H, Itokawa H. High performance liquid chromatography in phytochemical analysis of Eurycoma longifolia .  Planta Med. 1998;  64 741-5
• 2 Burkill I H. A dictionary of the economic products of the Malay Peninsula. vol.2 Kuala Lumpur; Government of Malaysia and Singapore 1966: pp 1000-1
• 3 Chan K L, Choo C Y, Abdullah N R, Ismail Z. Antiplasmodial studies of Eurycoma longifolia Jack using the lactate dehydrogenase assay of Plasmodium falciparum .  J Ethnopharmacol. 2004;  92 223-7
• 4 Chan K L, Iitaka Y, Noguchi H, Sugiyama H, Saito I, Sankawa U. 6α-hydroxyeurycomalactone, a quassinoid from Eurycoma longifolia .  Phytochemistry. 1992;  31 4295-8
• 5 Chan K L, Lee S P, Sam T W, Han B H. A quassinoid glycoside from the roots of Eurycoma longifolia .  Phytochemistry. 1989;  28 2857-9
• 6 Chan K L, Lee S P, Sam T W, Tan S C, Noguchi H, Sankawa U. 13β,18-Dihydroeurycomanol, a quassinoid from Eurycoma longifolia .  Phytochemistry. 1991;  30 3138-41
• 7 Chan K L, Lee S P, Yuen K H. Antipyretic Activity of Quassinoids from Eurycoma longifolia Jack.  In: Chemical prospecting in Malayan forest. Ghazally I, Murtedza M, Laily D, editors Selangor; Pelanduk Publications 1995: pp 219-24
• 8 Chan K L, O'Neill M J, Phillipson J D, Warhurst D C. Plants as sources of antimalarial drugs. Part 3. Eurycoma longifolia .  Planta Med. 1986;  52 105-7
• 9 Itokawa H, Kishi E, Morita H, Takeya K. Cytotoxic quassinoids and tirucallane-type triterpene from the woods of Eurycoma longifolia .  Chem Pharm Bull. 1992;  40 1053-5
• 10 Jiwajinda S, Santisopasri V, Murakami A, Kawanaka M, Kawanaka H, Gasquet M. et al . In vitro anti-tumor promoting and anti-parasitic activities of the quassinoids from Eurycoma longifolia, a medicinal plant in Southeast Asia.  J Ethnopharmacol. 2002;  82 55-8
• 11 Morita H, Kishi E, Takeya K, Itokawa H, Iitaka Y. Highly oxygenated quassinoids from Eurycoma longifolia .  Phytochemistry. 1993;  33 691-6
• 12 Morita H, Kishi E, Takeya K, Itokawa H, Tanaka O. New quassinoids from the roots of Eurycoma longifolia . Chem Lett 1990: 749-52
• 13 Tada H, Yasuda F, Otani K, Doteuchi M, Ishara Y, Shiro M. New antiulcer quassinoids from Eurycoma longifolia .  Eur J Med Chem. 1991;  26 345-9
• 14 Ang H H, Hitotsuyanagi Y, Fukaya H, Takeya K. Quassinoids from Eurycoma longifolia .  Phytochemistry. 2002;  59 833-7
• 15 Ang H H, Hitotsuyanagi Y, Takeya K. Eurycolactones A - C, novel quassinoids from Eurycoma longifolia .  Tetrahedron Lett. 2000;  41 6849-53
• 16 Bedir E, Abou-Gazar H, Ngwendson J N, Khan I A. Eurycomaoside: a new quassinoid-type glycoside from the roots of Eurycoma longifolia .  Chem Pharm Bull. 2003;  51 1301-3
• 17 Kuo P C, Damu A G, Lee K H, Wu T S. Cytotoxic and antimalarial constituents from the roots of Eurycoma longifolia .  Bioorg Med Chem. 2004;  12 537-44
• 18 Kuo P C, Shi L S, Damu A G, Su C R, Huang C H, Ke C H. et al . Cytotoxic and antimalarial β-carboline alkaloids from the roots of Eurycoma longifolia .  J Nat Prod. 2003;  66 1324-7
• 19 Kanchanapoom T, Kasai R, Chumsri P, Hiraga Y, Yamasaki K. Canthin-6-one and β-carboline alkaloids from Eurycoma harmandiana .  Phytochemistry. 2001;  56 383-6
• 20 Mitsunaga K, Koike K, Tanaka T, Ohkawa Y, Kobayashi Y, Sawaguchi T. et al . Canthin-6-one alkaloids from Eurycoma longifolia .  Phytochemistry. 1994;  35 799-802
• 21 Tan S, Yuen K H, Chan K L. HPLC analysis of plasma 9-methoxycanthin-6-one from Eurycoma longifolia and its application in a bioavailability/ pharmacokinetic study.  Planta Med. 2002;  68 355-8
• 22 Lin L C, Peng C Y, Wang S H, Lee K W, Wang S P. Reinvestigation of the chemical constituents of Eurycoma longifolia .  Chin Pharm J. 2001;  53 97-106
• 23 Morita H, Kishi E, Takeya K, Itokawa H, Iitaka Y. Squalene-derivatives from Eurycoma longifolia .  Phytochemistry. 1993;  34 765-71
• 24 Itokawa H, Kishi E, Morita H, Takeya K, Iitaka Y. A new squalene-type triterpene from the woods of Eurycoma longifolia . Chem Lett 1991: 2221-2
• 25 Itokawa H, Kishi E, Morita H, Takeya K, Iitaka Y. Eurylene, a new squalene-type triterpene from Eurycoma longifolia .  Tetrahedron Lett. 1991;  32 1803-4
• 26 Morita H, Kishi E, Takeya K, Itokawa H. Biphenylneolignans from wood of Eurycoma longifolia .  Phytochemistry. 1992;  31 3993-5
• 27 Biopharmaceutics Coordinating Committee in the Center for Drug Evaluation and R esearch, Center for Veterinary M edicine, Food and Drug A dministration. Guidance for industry. Bioanalytical method validation 2001: pp 1-22
• 28 Bourne D WA, Triggs E J, Eadie M J. Pharmacokinetics for the non-mathematical. Lancaster; MTP Press Ltd 1986: p 50-112
• 29 Kramer S D. Prediction from physicochemical parameters.  Pharm Sci Tech Today. 1999;  2 373-80